CELLDEX THERAPEUTICS INC (CLDX) Stock Analyst Ratings
USA - NASDAQ:CLDX - US15117B2025 - Common Stock
26.6 USD
-0.12 (-0.45%)
ChartMill assigns a Buy % Consensus number of 83% to CLDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 57.38. This target is 115.7% above the current price.
CLDX was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-21 | Mizuho | Initiate | Outperform |
| 2025-10-13 | Barclays | Initiate | Underweight |
| 2025-09-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-05-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-28 | Canaccord Genuity | Initiate | Buy |
| 2025-03-20 | Morgan Stanley | Initiate | Overweight |
| 2025-03-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | UBS | Initiate | Buy |
| 2025-01-29 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-07 | Citigroup | Initiate | Buy |
| 2024-09-30 | Goldman Sachs | Initiate | Neutral |
| 2024-09-27 | Wolfe Research | Downgrade | Outperform -> Peer Perform |